HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Richard Jove Selected Research
Richard Jove Research Topics
Disease
85
Neoplasms (Cancer)
11/2020 - 01/2000
17
Melanoma (Melanoma, Malignant)
05/2016 - 10/2002
14
Breast Neoplasms (Breast Cancer)
06/2018 - 01/2003
11
Neoplasm Metastasis (Metastasis)
05/2018 - 01/2002
11
Prostatic Neoplasms (Prostate Cancer)
02/2014 - 11/2002
11
Carcinogenesis
12/2011 - 01/2002
8
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2012 - 10/2002
7
Leukemia
05/2013 - 09/2002
6
Ovarian Neoplasms (Ovarian Cancer)
09/2020 - 01/2011
5
Carcinoma (Carcinomatosis)
03/2007 - 03/2004
3
Glioblastoma (Glioblastoma Multiforme)
01/2014 - 03/2003
3
Infections
07/2009 - 01/2000
3
Adenocarcinoma
08/2008 - 11/2002
2
Ascites
05/2018 - 12/2014
2
Obesity
06/2015 - 08/2013
2
Insulin Resistance
06/2015 - 08/2013
2
Glioma (Gliomas)
09/2014 - 04/2010
2
Osteosarcoma (Osteogenic Sarcoma)
11/2013 - 03/2007
2
Inflammation (Inflammations)
08/2013 - 11/2009
2
Neuroblastoma
07/2013 - 05/2012
2
Pancreatic Neoplasms (Pancreatic Cancer)
06/2013 - 03/2006
2
Medulloblastoma
04/2012 - 11/2008
2
Multiple Myeloma
02/2009 - 01/2000
2
Hematologic Neoplasms (Hematological Malignancy)
11/2008 - 09/2002
2
Hypoxia (Hypoxemia)
07/2008 - 08/2005
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2008 - 04/2007
2
Philadelphia Chromosome
05/2008 - 04/2007
2
Small Cell Carcinoma
07/2006 - 07/2003
2
Lung Neoplasms (Lung Cancer)
06/2006 - 07/2003
2
Blast Crisis (Blast Phase)
08/2003 - 10/2002
Drug/Important Bio-Agent (IBA)
19
Proteins (Proteins, Gene)
FDA Link
11/2014 - 10/2002
18
Phosphotransferases (Kinase)
IBA
05/2015 - 03/2002
14
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
05/2016 - 03/2002
14
src-Family Kinases
IBA
02/2014 - 10/2002
10
Small Interfering RNA (siRNA)
IBA
12/2014 - 03/2007
9
Dasatinib (BMS 354825)
FDA Link
09/2020 - 10/2005
9
Interleukin-6 (Interleukin 6)
IBA
04/2016 - 01/2000
9
Cytokines
IBA
12/2014 - 04/2002
7
DNA (Deoxyribonucleic Acid)
IBA
05/2012 - 07/2003
7
Tyrosine (L-Tyrosine)
FDA Link
08/2005 - 03/2002
6
Janus Kinases
IBA
11/2014 - 04/2002
6
Cyclin D1
IBA
11/2013 - 09/2005
5
Transcription Factors (Transcription Factor)
IBA
11/2014 - 01/2000
5
Survivin
IBA
02/2014 - 01/2006
5
ErbB Receptors (EGF Receptor)
IBA
06/2006 - 04/2002
4
MicroRNAs (MicroRNA)
IBA
11/2020 - 12/2010
4
Sorafenib (BAY 43-9006)
FDA Link
05/2016 - 11/2008
4
Messenger RNA (mRNA)
IBA
05/2016 - 08/2003
4
Histone Deacetylase Inhibitors
IBA
06/2011 - 08/2003
4
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
03/2010 - 03/2002
4
Imatinib Mesylate (Gleevec)
FDA Link
04/2007 - 10/2002
3
Paclitaxel (Taxol)
FDA Link
Generic
09/2020 - 06/2009
3
Janus Kinase Inhibitors
IBA
08/2019 - 06/2011
3
Fatty Acids (Saturated Fatty Acids)
IBA
06/2018 - 06/2015
3
Platinum
IBA
05/2018 - 12/2004
3
Interleukin-6 Receptors (Interleukin 6 Receptor)
IBA
04/2016 - 07/2013
3
Biomarkers (Surrogate Marker)
IBA
12/2014 - 01/2006
3
berbamine (penduline)
IBA
01/2014 - 10/2012
3
Interleukins
IBA
07/2013 - 09/2002
3
indirubin
IBA
06/2013 - 04/2005
3
Estrogen Receptors
IBA
06/2013 - 01/2006
3
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2011 - 04/2002
3
Epidermal Growth Factor (EGF)
IBA
08/2008 - 03/2003
2
Tyrosine Kinase Inhibitors
IBA
09/2020 - 09/2002
2
Doxorubicin (Adriamycin)
FDA Link
Generic
05/2018 - 01/2006
2
Formaldehyde (Formol)
FDA Link
01/2017 - 01/2006
2
Paraffin
IBA
01/2017 - 01/2006
2
Glucose (Dextrose)
FDA Link
Generic
06/2015 - 08/2013
2
Toll-Like Receptors (Toll-Like Receptor)
IBA
11/2014 - 09/2014
2
G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
IBA
11/2014 - 12/2010
2
Caspase 3 (Caspase-3)
IBA
11/2013 - 04/2005
2
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
11/2013 - 01/2012
2
Fibronectins (Fibronectin)
IBA
12/2012 - 02/2009
2
sphingosine 1-phosphate (sphingosine-1-phosphate)
IBA
05/2012 - 12/2010
2
Proteasome Inhibitors
IBA
04/2012 - 01/2000
2
Apoptosis Regulatory Proteins
IBA
04/2012 - 11/2008
2
Annexin A5
IBA
01/2012 - 06/2011
2
Chromatin
IBA
12/2011 - 12/2008
2
RNA (Ribonucleic Acid)
IBA
12/2011 - 07/2008
2
AZD 1480
IBA
11/2011 - 12/2009
2
NF-kappa B (NF-kB)
IBA
11/2009 - 04/2009
2
bosutinib
IBA
06/2009 - 05/2008
2
Phosphotyrosine
IBA
06/2009 - 03/2003
2
bcr-abl Fusion Proteins
IBA
12/2008 - 10/2002
2
Mitogen-Activated Protein Kinase 3
IBA
11/2008 - 03/2003
2
Proto-Oncogene Proteins c-akt (Protein Kinase B)
IBA
11/2008 - 11/2005
2
Androgens
IBA
03/2007 - 07/2006
2
Antisense Oligonucleotides
IBA
01/2006 - 03/2002
2
Hydroxamic Acids (Hydroxamic Acid)
IBA
04/2005 - 08/2003
2
Histone Deacetylases (Histone Deacetylase)
IBA
04/2005 - 08/2003
2
tanespimycin (17AAG)
IBA
04/2005 - 10/2002
2
PD 180970
IBA
07/2003 - 10/2002
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
12/2002 - 10/2002
2
Ligands
IBA
04/2002 - 01/2002
1
Membrane Proteins (Integral Membrane Proteins)
IBA
11/2020
1
Sunitinib (Sutent)
FDA Link
09/2020
Therapy/Procedure
24
Therapeutics
11/2020 - 01/2000
7
Drug Therapy (Chemotherapy)
11/2020 - 12/2003
2
Immunotherapy
01/2006 - 09/2003
1
Palliative Care (Palliative Therapy)
11/2020